Labcorp Holdings Inc.
NYSE:LH
Sector
Location
Market Cap
USD 22.09 B
Share Price
USD 265.85
Avg Daily Volume
741,211
Change (1 day)
2.27%
Change (1 year)
18.29%
Change (YTD)
15.93%
Labcorp Holdings Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2025: USD 1.69 B
Labcorp Holdings Inc. Operating Cash Flow is USD 1.69 B for the Trailing 12 Months (TTM) ending June 30, 2025, a 22.16% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Labcorp Holdings Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2024 was USD 1.39 B, a -7.57% change year over year.
-
Labcorp Holdings Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2023 was USD 1.50 B, a -37.33% change year over year.
-
Labcorp Holdings Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2022 was USD 2.39 B, a -25.34% change year over year.
-
Labcorp Holdings Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2021 was USD 3.21 B, a 100.36% change year over year.
StockViz
Competitors
Fresenius SE & Co. KGaA
USD 50.92
FRE.DE
+1.60
3.26%
Sino Biopharmaceutical Limited
USD 0.94
1177.HK
+0.01
0.99%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 7.84
603392.SS
-0.02
-0.30%
Shenzhen New Industries Biomedical Engineering Co., Ltd.
USD 7.66
300832.SZ
-0.07
-0.94%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
USD 2.27
0874.HK
-0.02
-0.80%
Humanwell Healthcare (Group) Co.,Ltd.
USD 3.00
600079.SS
-0.03
-1.05%
AddLife AB (publ)
USD 17.10
ALIF-B.ST
-0.17
-1.00%
Guangzhou Kingmed Diagnostics Group Co., Ltd.
USD 4.20
603882.SS
-0.07
-1.63%
Eli Lilly and Company
USD 625.65
LLY
-15.21
-2.37%
AbbVie Inc.
USD 198.05
ABBV
-0.81
-0.41%
Roche Holding AG
USD 318.77
RO.SW
-3.47
-1.08%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Novartis AG
USD 116.31
NOVN.SW
+1.16
1.00%
Novo Nordisk A/S
USD 50.40
NOVO-B.CO
+2.25
4.67%
Merck & Co., Inc.
USD 80.69
MRK
+0.32
0.40%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Fresenius SE & Co. KGaA
USD 50.92
FRE.DE
+1.60
3.26%
Sino Biopharmaceutical Limited
USD 0.94
1177.HK
+0.01
0.99%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 7.84
603392.SS
-0.02
-0.30%
Shenzhen New Industries Biomedical Engineering Co., Ltd.
USD 7.66
300832.SZ
-0.07
-0.94%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
USD 2.27
0874.HK
-0.02
-0.80%
Humanwell Healthcare (Group) Co.,Ltd.
USD 3.00
600079.SS
-0.03
-1.05%
AddLife AB (publ)
USD 17.10
ALIF-B.ST
-0.17
-1.00%
Guangzhou Kingmed Diagnostics Group Co., Ltd.
USD 4.20
603882.SS
-0.07
-1.63%
Eli Lilly and Company
USD 625.65
LLY
-15.21
-2.37%
AbbVie Inc.
USD 198.05
ABBV
-0.81
-0.41%
Roche Holding AG
USD 318.77
RO.SW
-3.47
-1.08%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Novartis AG
USD 116.31
NOVN.SW
+1.16
1.00%
Novo Nordisk A/S
USD 50.40
NOVO-B.CO
+2.25
4.67%
Merck & Co., Inc.
USD 80.69
MRK
+0.32
0.40%